Docetaxel (Taxotere) in recurrent high grade mucoepidermoid carcinoma of the major salivary glands

Oral Oncology Extra

Volumn 40, Issue 1, 2004, Pages 5-7

  Raguse, Jan Dirk ^a   Gath, Hans Joachim ^a   Bier, Jürgen ^a   Riess, Hanno ^a   Oettle, Helmut ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Chemotherapy; Head and neck tumour; Mucoepidermoid carcinoma

Indexed keywords

EID: 23844524436     PISSN: None     EISSN: 17419409     Source Type: Journal    
DOI: 10.1016/S1741-9409(03)00003-7     Document Type: Article

References (20)

1. Lopes MA, Santos GC, Kowalski LP. Multivariate survival analysis of 128 cases of oral cavity minor salivary gland carcinomas. Head Neck 1998;20(8):699-706.
2. Loyola AM, de Araujo VC, de Sousa SO, de Araujo NS. Minor salivary gland tumours. A retrospective study of 164 cases in a Brazilian population. Eur J Cancer B Oral Oncol 1995;31B(3):197-201.
3. Speight PM, Barrett AW. Salivary gland tumours. Oral Dis 2002;8(5):229-40.
4. Guzzo M, Andreola S, Sirizzotti G, Cantu G. Mucoepidermoid carcinoma of the salivary glands clinicopathologic review of 108 patients treated at the National Cancer Institute of Milan. Ann Surg Oncol 2002;9(7):688-95.
5. Borthne A, Kjellevold K, Kaalhus O, Vermund H. Salivary gland malignant neoplasms treatment and prognosis. Int J Radiat Oncol Biol Phys 1986;12(5):747-54.
6. Harrison LB, Armstrong JG, Spiro RH, Fass DE, Strong EW. Postoperative radiation therapy for major salivary gland malignancies. J Surg Oncol 1990;45(1):52-5.
7. Posner MR, Ervin TJ, Weichselbaum RR, Fabian RL, Miller D. Chemotherapy of advanced salivary gland neoplasms. Cancer 1982;50(11):2261-4.
8. Kaplan MJ, Johns ME, Cantrell RW. Chemotherapy for salivary gland cancer. Otolaryngol Head Neck Surg 1986;95(2):165-70.
9. Healey WV, Perzin KH, Smith L. Mucoepidermoid carcinoma of salivary gland origin. Classification, clinical-pathologic correlation, and results of treatment. Cancer 1970;26(2):368-88.
10. McNaney D, McNeese MD, Guillamondegui OM, Fletcher GH, Oswald MJ. Postoperative irradiation in malignant epithelial tumours of the parotid. Int J Radiat Oncol Biol Phys 1983;9(9):1289-95.
11. Goode RK, Auclair PL, Ellis GL. Mucoepidermoid carcinoma of the major salivary glands clinical and histopathologic analysis of 234 cases with evaluation of grading criteria. Cancer 1998;82(7):1217-24.
12. Spiro RH. Salivary neoplasms overview of a 35-year experience with 2,807 patients. Head Neck Surg 1986;8(3):177-84.
13. Airoldi M, Pedani F, Succo G, et al. Phase II randomized trial comparing vinorelbine versus vinorelbine plus cisplatin in patients with recurrent salivary gland malignancies. Cancer 2001;91(3):541-7.
14. Licitra L, Marchini S, Spinazze S, et al. Cisplatin in advanced salivary gland carcinoma. A phase II study of 25 patients. Cancer 1991;68(9):1874-7.
15. Dreyfuss AI, Clark JR, Fallon BG, Posner MR, Morris CM358Jr, Miller D. Cyclophosphamide, doxorubicin, and cisplatin combination chemotherapy for advanced carcinomas of salivary gland origin. Cancer 1987;60(12):2869-72.
16. Triozzi PL, Brantley A, Fisher S, Cole TB, Crocker I, Huang AT. 5-Fluorouracil, Cyclophosphamide, and vincristine for adenoid cystic carcinoma of the head and neck. Cancer 1987;59(5):887-90.
17. Forastiere AA, Neuberg D, Taylor 4th SG, DeConti R, Adams G. Phase II evaluation of Taxol in advanced head and neck cancer: an Eastern Cooperative Oncology group trial. J Natl Cancer Inst Monogr 1993;15:181-4.
18. Catimel G, Verweij J, Mattijssen V, et al. Docetaxel (Taxotere) an active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials Group Ann Oncol 1994;5(6):533-7.
19. Piechocki MP, Lonardo F, Ensley JF, Nguyen T, Kim H, Yoo GH. Anticancer activity of docetaxel in murine salivary gland carcinoma. Clin Cancer Res 2002;8(3):870-7.
20. Belli F, Di Lauro L, Zappanico A, Giunta S. Docetaxel in the treatment of metastatic carcinoma of the salivary glands report of a case. Clin Ter 1999; 150(1):77-9.